Inhibrx Reports First Quarter 2026 Financial Results
1 hour ago
SAN DIEGO, May 14, 2026 /PRNewswire/ -- Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company") today reported financial results for the first quarter of 2026. The biopharmaceutical company has two programs in ongoing clinical trials. Recent Corporate Highlights and Upcoming...
...
Read the fullstory
It's better on the More. News app
✅ It’s fast
✅ It’s easy to use
✅ It’s free
More. from PR Newswire ⬇️
